You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Suppliers and packagers for generic ingredient: UPADACITINIB


✉ Email this page to a colleague

« Back to Dashboard


UPADACITINIB

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

ApplicantTradenameGeneric NameDosageNDANDA/ANDASupplierPackage CodePackageMarketing Start
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675 NDA AbbVie Inc. 0074-1043-14 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-14) 2019-08-16
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675 NDA AbbVie Inc. 0074-1043-28 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-28) 2019-08-16
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675 NDA AbbVie Inc. 0074-2306-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-30) 2019-08-16
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675 NDA AbbVie Inc. 0074-2306-70 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-70) 2019-08-16
>Applicant>Tradename>Generic Name>Dosage>NDA>NDA/ANDA>Supplier>Package Code>Package>Marketing Start
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing